Method Article
The fibroblast explant culture protocol from human skin punch biopsies is a technically robust and simple way to derive skin cells within 4-8 weeks for banking of about 15-20 million cells at a low passage number.
Tissues and cell lines derived from an individual with disease are ideal sources to study disease-related cellular phenotypes. Patient-derived fibroblasts in this protocol have been successfully used in the derivation of induced pluripotent stem cells to model disease1. Early passages of these fibroblasts can also be used for cell-based functional assays to study specific disease pathways, mechanisms2 and subsequent drug screening approaches. The advantage of the presented protocol over enzymatic procedures are 1) the reproducibility of the technique from small amounts of tissue derived from older patients, e.g. patients affected with Parkinson's disease, 2) the technically simple approach over more challenging methodologies using enzymatic treatments, and 3) the time consideration: this protocol takes 15-20 min and can be performed immediately after biopsy arrival. Enzymatic treatments can take up to 4 hr and have the problems of overdigestion, reduction of cell viability and subsequent attachment of cells when not handled properly. This protocol describes the dissection and preparation of a 4-mm human skin biopsy for derivation of a fibroblast culture and has a very high success rate which is important when dealing with patient-derived tissue samples. In this culture, keratinocytes migrate out of the biopsy tissue within the first week after preparation. Fibroblasts appear 7-10 days after the first outgrowth of keratinocytes. DMEM high glucose media supplemented with 20% FBS favors the growth of fibroblasts over keratinocytes and fibroblasts will overgrow the keratinocytes. After 2 passages keratinocytes have been diluted out resulting in relatively homogenous fibroblast cultures which expresses the fibroblast marker SERPINH1 (HSP-47). Using this approach, 15-20 million fibroblasts can be derived in 4-8 weeks for cell banking. The skin dissection takes about 15-20 min, cells are then monitored once a day under the microscope, and media is changed every 2-3 days after attachment and outgrowth of cells.
The skin punch biopsy obtained using standard procedure3 (e.g. obtained with 4mm round Visipunch instrument) should be kept in complete DMEM 20% FBS media on ice. Once the sample has arrived in the laboratory, process the biopsy as soon as possible.
1. Preparation of the Skin Punch Biopsy
STEPS 1.1- 1.3 ARE TO BE PERFORMED INSIDE A BIOSAFETY CABINET
2. Dissection of the Skin Punch Biopsy
STEPS 9 2.1-2.2 ARE TO BE PERFORMED INSIDE A HORIZONTAL LAMINAR FLOW HOOD
3. Transfer of Dissected Skin Biopsy Pieces into Tissue Culture Plates
STEPS 3.1-3.6 ARE TO BE PERFORMED INSIDE A BIOSAFETY CABINET
4. Characterization the Fibroblasts through Immunostaining
Keratinocytes growing out of the biopsy pieces as soon as 48 hr after dissection. First fibroblasts outgrowth can be observed about one week after processing. Once the wells have reached confluency, fibroblasts are passaged for two more passages to reach three 150 cm flasks (T150) and cells are cryopreserved. We generate with this method 15-20 million cells. The fibroblasts are positive for anti-SERPINH1 (also known as HSP-47) (Figure 1), which is a collagen-specific molecular chaperone localized in the endoplasmic reticulum. HSP47 plays an essential role in collagen biosynthesis in skin fibroblasts (Kuroda, et al., 2004)5.
TIME LINE
Day | Expectation |
Day 3- Day 7 | Attachment and outgrowth of keratinocytes |
Day 7- Day 14 | Outgrowth of fibroblasts |
Day 25-Day 35 | Fibroblasts should cover the 6-well plate and should be for passaged into 75cm flasks, passage a second time into 150cm flasks |
Day 30-Day 50 | Freeze down as 1Mio cells/vial about 15-20 Mio cells in complete DMEM media plus 10% DMSO |
Figure 1. Anti-SERPHIN1 immunohistochemistry of patient-derived fibroblast culture with DAPI counterstaining.
With this protocol, relatively pure cultures of skin fibroblasts can be obtained. The fibroblasts have characteristic morphological features of elongated, spindle-like cell bodies, round to oval cell nuclei, and the fibroblasts grow aligned and in bundles when confluent. The media supports the growth of fibroblasts whereas other cell populations e.g. keratinocytes need additional supplements and growth factors, or are mitotically less active, this allows for relatively pure fibroblast cultures.
The fibroblasts are subsequently passaged with trypsin at a 1:3 to 1:5 ratio. The culture is expanded to the desired quantity of fibroblasts (15-20 Million) within 4-8 weeks.
Using this technique, our laboratory has derived over 70 fibroblast lines successfully. We have tested every line for mycoplasma contamination and add antibiotics to the growth media to avoid other bacterial contamination. For the initial explant culture we found that 20% FBS in the media supports the growth, however, in later passages 10% FBS is sufficient. Occasionally, we observe a direct outgrowth of fibroblasts from the skin pieces presumably due to the cutting angle of the skin and the removal of the epidermis which contains keratinocytes.
A similar technique using a coverslip to hold down the skin pieces was less effective in our hands4. Due to the movement of the coverslip within culture dish -even when handled with great care- the skin pieces did not attach properly.
The authors have nothing to disclose.
Development of this protocol was funded by the California Institute for Regenerative Medicine (CIRM, TR1-01246) and Parkinson Alliance.
Name | Company | Catalog Number | Comments |
Dissecting microscope | Leica | S6E | |
10 cm Tissue Culture Petri dish | VWR | 25382-166 | |
6-well Tissue Culture plate | VWR | 73520-906 | |
Stainless steel disposable sterile scalpels (2), blade No#15, Miltex | VWR | 21909-660 | |
Sterile pointed-tip forceps | |||
50 mL Conical tubes | VWR | 21008-940 | |
2 mL Serological Pipettes | VWR | 89130-894 | |
5 mL Serological Pipettes | VWR | 89130-896 | |
10 mL Serological Pipettes | VWR | 89130-898 | |
Pasteur Pipettes | VWR | 14672-380 | |
Table A. Table of specific reagents and equipments. | |||
1X DMEM: High Glucose | Invitrogen/Gibco | 11960-069 | |
20% Fetal Bovine Serum | Invitrogen/Gibco | 26140-079 | |
1X L-Glutamine | Invitrogen/Gibco | 25030-164 | |
1X MEM Non-essential Amino Acids | Invitrogen/Gibco | 11140-076 | |
1X Penicillin/Streptomycin | Invitrogen/Gibco | 15140-163 | |
Table B. Reagents. |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved